HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of fluvoxamine against ischemia/reperfusion injury in isolated, perfused guinea-pig hearts.

Abstract
Serotonin (5-hydroxytryptamine; 5-HT) is known to be activated during ischemia-reperfusion and triggers contractile dysfunction and pathological apoptosis. Here, the beneficial effects of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine was demonstrated on ischemia-reperfusion injury in guinea-pig hearts perfused using the Langendorff technique. The recovery (%) of left ventricular developed pressure (LVDP) by fluvoxamine (5×10(-8) M) was 95.4% (control: 32%), which was consistent with the inhibition of mitochondrial Ca(2+)([Ca(2+)]m) uptake induced by changes in the Ca(2+) content and acidification of the perfusate, and similar to reperfusion following global ischemia in Langendorff-perfused hearts. Fluvoxamine inhibited the increase in [Ca(2+)]m induced by changes in the Ca(2+) content of the perfusate in perfused preparations of mitochondria, which was similar to the results obtained with the mitochondrial permeability transition pore (MPTP) opener atractyroside. The terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL)-positive cells were significantly less in fluvoxamine-treated hearts than in control hearts, with decreases in caspase-3 activity. These results suggest that SSRI inhibits opening of the MPTP by preventing [Ca(2+)]m overload-induced apoptosis related to the endogenous accumulation of 5-HT in ischemia-reperfusion hearts.
AuthorsTatsuya Muto, Haruki Usuda, Aya Yamamura, Koji Yoshida, Ai Ohashi, Kumiko Mitsui-Saitoh, Junichi Sakai, Yumi Sugimoto, Hideki Mizutani, Tsunemasa Nonogaki, Yoshihiro Hotta
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 37 Issue 5 Pg. 731-9 ( 2014) ISSN: 1347-5215 [Electronic] Japan
PMID24789996 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Serotonin Uptake Inhibitors
  • Atractyloside
  • Caspase 3
  • Fluvoxamine
  • Calcium
Topics
  • Animals
  • Apoptosis (drug effects)
  • Atractyloside (pharmacology)
  • Calcium (metabolism)
  • Caspase 3 (metabolism)
  • Fluvoxamine (pharmacology, therapeutic use)
  • Guinea Pigs
  • Heart (drug effects)
  • In Vitro Techniques
  • Mitochondria (metabolism)
  • Myocardium (cytology, metabolism)
  • Perfusion
  • Reperfusion Injury (drug therapy, metabolism)
  • Selective Serotonin Reuptake Inhibitors (pharmacology, therapeutic use)
  • Ventricular Pressure (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: